Core Viewpoint - Everest Group, Ltd. (EG) is trading at a discount compared to the industry, with a price-to-book value of 0.93X versus the industry average of 2.53X, and holds a Value Score of A [1] Group 1: Price Performance - Shares of Everest Group have declined by 7.9% year-to-date, underperforming the Finance sector and the Zacks S&P 500 composite, which grew by 13.6% and 13.4% respectively [3] - The market capitalization of Everest Group is $13.9 billion, with an average trading volume of 0.4 million shares over the last three months [3] Group 2: Financial Projections - The Zacks Consensus Estimate for Everest Group's 2025 revenues is $17.7 billion, reflecting a year-over-year increase of 2.3% [5] - The consensus estimate for current-year earnings is $45.51 per share, indicating a growth of 52.6% from the previous year [5] - Projections for 2026 earnings per share and revenues suggest year-over-year increases of 33.6% and 4.8% respectively [5] Group 3: Business Strategy and Growth - Everest Group is diversifying its products and regions, which supports steady and sustainable growth, while reducing reliance on North America [8][12] - The company is expanding its presence in Asia, Latin America, and Europe, enhancing underwriting agility and risk-adjusted returns [12] - A conservative investment strategy, with over 75% of assets in investment-grade fixed income, positions the company to benefit from a higher-rate environment [14] Group 4: Financial Health - Everest Group's debt-to-capital ratio is 19.3%, significantly lower than the industry average of 34.2%, indicating strong financial flexibility [15] - The times interest earned ratio stands at 447x, compared to the industry average of 11.5x, showcasing a disciplined approach to leverage [15] Group 5: Profitability Metrics - The return on equity for Everest Group is 5.9%, which is below the sector average of 14.8%, highlighting challenges in capital efficiency [17] - The combined ratio for the second quarter increased by 10 basis points year-over-year to 90.4%, indicating ongoing exposure to catastrophic losses [16] Group 6: Shareholder Value - The company has raised dividends four times in the past five years, resulting in an annualized growth rate of 11.7% and a current payout ratio of 40% [18] - A $10 million share repurchase program has been authorized, reflecting a commitment to rewarding investors [18] Conclusion - Overall, Everest Group is supported by product diversification, higher premium volumes, and disciplined financial management, but faces challenges related to catastrophe losses and profitability metrics [19]

SANTA CLARA, Calif. and PUNE, India, Sept. 17, 2025 /PRNewswire/ -- Persistent Systems (BSE: 533179) (NSE: PERSISTENT), a global Digital Engineering and Enterprise Modernization leader, today announced that it has been recognized as a 2025 Elevate Honors recipient in the 'Growth Honor of the Year' category by Everest Group, which highlights companies with annual revenue between $1–5 billion. This acknowledgement affirms the Company's strong growth trajectory with a commitment to driving long-term value acro ...

Leaders recognition highlights Broadridge's successful accelerated strategy to invest in technology and innovation to drive business value for its BPO clients across capital markets, wealth and asset management NEW YORK , Sept. 15, 2025 /PRNewswire/ -- Broadridge Financial Solutions, Inc. (NYSE: BR), a global Fintech leader, today announced its recognition as a Leader in capital markets operations by independent research firm Everest Group in its 2025 Capital Markets Operations Services PEAK Matrix® Assessm ...

Everest Group, Ltd. (NYSE:EG) is one of the best cheap stocks to buy for beginners. On September 4, Everest Group, Ltd.’s (NYSE:EG) insurance division Everest Insurance announced the launch of EverBuild™, which is an “enhanced Builder’s Risk coverage form”. Everest Group, Ltd. (EG): Among Top Stocks to Buy from Joe DiMenna’s Portfolio Management reported that the new offering highlights Everest Group, Ltd.’s (NYSE:EG) long-standing commitment to the construction industry with specialized and innovative s ...

Core Insights - Silver Scott Mines, Inc. has signed a development agreement with Everest Networks to redevelop Kanab.club into a cannabis-focused consumer social network [1] - The agreement includes the creation of the Kanab Token, aimed at enhancing user engagement and providing transactional utility on the platform [1] Company Developments - The partnership with Everest Networks signifies a strategic move towards integrating social networking and business tools specifically for the cannabis industry [1] - The redevelopment of Kanab.club is expected to cater to the needs of cannabis consumers and industry participants, potentially expanding the user base and increasing platform activity [1] Industry Implications - The introduction of the Kanab Token may facilitate transactions within the cannabis sector, promoting a more interactive and engaged community [1] - This dual-platform strategy could position the company favorably within the growing cannabis market, leveraging social networking to enhance business opportunities [1]

Group 1 - Everest Group's shares have underperformed over the past year, losing over 12% of their value [1] - The decline in share value has persisted since the company added reserves amid a management reshuffle in January [1]

Core Insights - Medidata has been recognized as a Leader in Everest Group's Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix® Assessment 2025, highlighting its success in delivering impactful solutions in the life sciences industry [1][4] - The company has maintained its leadership in the eCOA market for over a decade, with its solutions foundational to thousands of global studies across various indications [2][3] - Medidata eCOA significantly reduces study design and startup timelines, with a reduction of up to six weeks compared to the industry standard of 12 or more weeks [2] Company Achievements - Medidata's eCOA has been enhanced through a partnership with Cogstate, focusing on reducing rater burden and improving signal detection in Central Nervous System (CNS) trials [2] - The company has received consistent recognition from Everest Group in 2023 and 2024 for its Decentralized Clinical Trials, reinforcing its leadership in the clinical trial space [4] - Medidata Rave EDC and Medidata Rave CTMS have also been acknowledged, showcasing the company's commitment to improving clinical trial operations and accelerating the delivery of therapies [4] Industry Impact - Medidata has powered over 36,000 trials and 11 million patients, offering industry-leading expertise and one of the largest clinical trial data sets [6] - The company serves approximately 2,300 customers, with more than 1 million registered users relying on its end-to-end platform to enhance patient experiences and expedite clinical breakthroughs [6]

Core Insights - YPrime has been recognized as a Leader in the Everest Group's Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix® Assessment 2025, highlighting its capability to deliver advanced technology and operational excellence in complex clinical trials [1][2][3] Company Achievements - The recognition as a Leader reflects YPrime's role as a trusted partner to pharmaceutical companies, biotechs, and CROs, enabling faster study launches with high-quality eCOA solutions [2][3] - YPrime was previously named a Trailblazer in Patient Engagement by Everest Group in 2024, further validating its leadership in developing patient-friendly digital tools [6] Technological Innovations - YPrime's eCOA platform is designed to scale with the complexity of global clinical trials, featuring AI-powered localization tools that automate translation processes, supporting deployments in over 250 languages across 100+ countries [3] - The Automated Data Change Form (DCF) allows site staff to execute protocol-compliant data edits in minutes, improving speed and data integrity [4] - YPrime's glucometer eCOA integration, developed with diabetes patients, enhances real-time glucose monitoring, improving patient adherence and data compliance in metabolic trials [5] Operational Excellence - YPrime's eCOA platform enhances participant compliance through an intuitive app and design, streamlining site workflows and supporting sponsors with decision-making dashboards [7]

Company Overview - Everest Group is a Delaware reinsurance company established in 1999, based in Warren, NJ, and operates as a property and casualty insurer and reinsurer across the U.S., District of Columbia, Puerto Rico, and Guam [11] - As of December 31, 2024, Everest Reinsurance reported a statutory surplus of $5.6 billion [11] - The company's strategy focuses on maintaining leadership in targeted reinsurance and insurance markets, effective management throughout the underwriting cycle, and achieving attractive returns for shareholders [11] Investment Ratings - Everest Group holds a Zacks Rank of 3 (Hold) and has a VGM Score of B, indicating a solid position in the market [12] - The company has a Value Style Score of A, supported by favorable valuation metrics such as a forward P/E ratio of 7.54, making it appealing to value investors [12] Earnings Estimates - In the last 60 days, four analysts have revised their earnings estimates for Everest Group upwards, with the Zacks Consensus Estimate increasing by $0.11 to $45.51 per share for fiscal 2025 [12] - The company has demonstrated an average earnings surprise of +3.4%, indicating a positive trend in earnings performance [12] Investment Consideration - With a strong Zacks Rank and high Value and VGM Style Scores, Everest Group is recommended for investors looking for potential opportunities in the reinsurance sector [13]

Core Viewpoint - Everest Group, Ltd. is currently experiencing a short-term bearish trend as its shares trade below the 50-day simple moving average, indicating potential resistance levels for traders and analysts [1] Price Performance - Shares of Everest Group have declined by 8.4% year-to-date, underperforming the Finance sector's growth of 10.7% and the Zacks S&P 500 Composite's growth of 9.6% [2] - The company has a market capitalization of $13.9 billion, with an average trading volume of 0.4 million shares over the last three months [2] Valuation Metrics - Everest Group's shares are trading at a price-to-book value of 0.93X, which is lower than the industry average of 2.19X, indicating that the shares are affordable [4] Growth Projections - The Zacks Consensus Estimate for Everest Group's 2025 revenues is $17.6 billion, reflecting a year-over-year growth of 2.2% [9] - The consensus estimate for current-year earnings is $45.39 per share, suggesting a significant growth of 52.2% from the previous year [9] - Projections for 2026 indicate earnings per share and revenues will increase by 34.6% and 4.8%, respectively [9] Analyst Sentiment - Analysts have recently lowered their earnings estimates for both 2025 and 2026, with a 1.2% decrease for 2025 and a 0.9% decrease for 2026 [12] Strategic Expansion - Everest Group is expanding its operations globally, reducing risk concentration in North America and enhancing diversification across over 100 countries [8][15] - The company ranks as the 4th largest P&C reinsurer, benefiting from a diversified portfolio and lower catastrophe volatility [8][16] Financial Stability - The company maintains a strong balance sheet with a debt-to-capital ratio of 19.3%, significantly below the industry average of 34.4% [18] - Its times interest earned ratio stands at 447x, far exceeding the industry's 11.5x, indicating robust financial flexibility [18] Investment Income - Net investment income is on the rise, supported by a conservative and diversified portfolio, with over 75% allocated to investment-grade fixed income [17] Shareholder Value - Everest Group has increased its dividend four times in the last five years, with a five-year annualized dividend growth rate of 11.7% [21] - The company has also approved a share buyback program worth $10 million [21] Conclusion - Everest Group benefits from strong organic growth, a conservative investment portfolio, and a solid balance sheet, which support earnings stability and risk-adjusted returns [22] - However, challenges remain due to exposure to catastrophe losses and a return on equity that lags behind the industry average [22]